Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 1296Carcinoma, Non-Small-Cell Lung 793Neoplasms 787Colorectal Neoplasms 762Stomach Neoplasms 588Carcinoma, Hepatocellular 581Prostatic Neoplasms 514Lung Neoplasms 466Pancreatic Neoplasms 421Rectal Neoplasms 336Recurrence 315Neoplasm Metastasis 310Leukemia, Myeloid, Acute 293Colonic Neoplasms 283Multiple Myeloma 281Lymphoma 276Esophageal Neoplasms 273Uterine Cervical Neoplasms 272Ovarian Neoplasms 263Melanoma 246Head and Neck Neoplasms 245Precursor Cell Lymphoblastic Leukemia-Lymphoma 210Brain Neoplasms 195Lymphoma, Large B-Cell, Diffuse 187Nasopharyngeal Carcinoma 182Leukemia 173Lymphoma, Non-Hodgkin 172Liver Neoplasms 165Glioblastoma 160Polycystic Ovary Syndrome 157

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interventional × Ataxia Telangiectasia × Clear all
NCT03357978 2017-11-30

Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

Johann Wolfgang Goethe University Hospital

Phase NA Unknown
30 enrolled

Ataxia Telangiectasia, Immunologic Deficiency Syndromes, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡